← back to search

Kevin J. Klos

Vion Pharmaceuticals (United States) ·
Area of research
Neurology · Health, Toxicology and Mutagenesis
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Amyotrophic Lateral Sclerosis Research, and Botulinum Toxin and Related Neurological Disorders.
h-index
24
citations
4,105
works
43
NIH funding
primary concept
Medicine
email

Recent publications

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
The Lancet Neurology 2023cited by 122position: middledoi
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
The Lancet Neurology 2022cited by 190position: middledoi
Implementing Levodopa‐Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners
Movement Disorders Clinical Practice 2018cited by 24position: middledoi
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
JAMA 2016cited by 395position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David G. Standaert · University of Alabama at Birmingham2 papers (2018–2022) · 2 papers (2018–2022)Weining Robieson · AbbVie (United States)1 papers (2022–2022)Michelle A. Burack · University of Rochester Medical Center1 papers (2018–2018)Cindy Zadikoff · AbbVie (United States)1 papers (2018–2018)Saritha Talapala · AbbVie (United States)1 papers (2022–2022)Hui Zheng · Hunan University of Traditional Chinese Medicine1 papers (2022–2022)Kumar Budur · AbbVie (United States)1 papers (2022–2022)Maurizio Facheris · AbbVie (United States)1 papers (2022–2022)Nahome Fisseha · Virginia Commonwealth University1 papers (2022–2022)Eleni Okeanis Vaou · The University of Texas Health Science Center at Houston1 papers (2022–2022) · 1 papers (2022–2022)Robert A. Hauser · University of South Florida1 papers (2022–2022) · 1 papers (2022–2022)Hubert H. Fernandez · Universidade Federal do Rio Grande do Sul1 papers (2018–2018)Arvydas Vanagunas · Northwestern University1 papers (2018–2018) · 1 papers (2018–2018)Anna Jeong · AbbVie (United States)1 papers (2022–2022)Victor S.C. Fung · The University of Sydney1 papers (2022–2022) · 1 papers (2022–2022)